These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37701975)

  • 1. First report of Tunisian patients with CDKL5-related encephalopathy.
    Charfi Triki C; Zouari Mallouli S; Ben Jdila M; Ben Said M; Kamoun Feki F; Weckhuysen S; Masmoudi S; Fakhfakh F
    Epilepsia Open; 2024 Jun; 9(3):906-917. PubMed ID: 37701975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and gene mutational spectrum of CDKL5-related diseases in a cohort of Chinese patients.
    Zhao Y; Zhang X; Bao X; Zhang Q; Zhang J; Cao G; Zhang J; Li J; Wei L; Pan H; Wu X
    BMC Med Genet; 2014 Feb; 15():24. PubMed ID: 24564546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key clinical features to identify girls with CDKL5 mutations.
    Bahi-Buisson N; Nectoux J; Rosas-Vargas H; Milh M; Boddaert N; Girard B; Cances C; Ville D; Afenjar A; Rio M; Héron D; N'guyen Morel MA; Arzimanoglou A; Philippe C; Jonveaux P; Chelly J; Bienvenu T
    Brain; 2008 Oct; 131(Pt 10):2647-61. PubMed ID: 18790821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel CDKL5 mutations were found in patients in China: retrospective investigation in cases of CDKL5-related disorders.
    Yan Y; He D; Wu J; Hou R; Sun K; Li L
    Ital J Pediatr; 2020 Feb; 46(1):27. PubMed ID: 32111237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evolution and epilepsy outcome in three patients with CDKL5-related developmental encephalopathy.
    Bernardo P; Ferretti A; Terrone G; Santoro C; Bravaccio C; Striano S; Coppola A; Striano P
    Epileptic Disord; 2019 Jun; 21(3):271-277. PubMed ID: 31225800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical usefulness of serial EEG examinations in the diagnostic of hereditary epileptic encephalopathies case of severe epileptic encephalopathy type 2].
    Terczyńska I; Mierzewska H; Szczepanik E; Antczak-Marach D
    Przegl Lek; 2010; 67(9):757-61. PubMed ID: 21387820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical manifestation of CDKL5 deficiency disorder and identified mutations in a cohort of Slovak patients.
    Kluckova D; Kolnikova M; Medova V; Bognar C; Foltan T; Svecova L; Gnip A; Kadasi L; Soltysova A; Ficek A
    Epilepsy Res; 2021 Oct; 176():106699. PubMed ID: 34229227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.
    Demarest ST; Olson HE; Moss A; Pestana-Knight E; Zhang X; Parikh S; Swanson LC; Riley KD; Bazin GA; Angione K; Niestroj LM; Lal D; Juarez-Colunga E; Benke TA
    Epilepsia; 2019 Aug; 60(8):1733-1742. PubMed ID: 31313283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of early myoclonic encephalopathy caused by a CDKL5 mutation.
    Takeda K; Miyamoto Y; Yamamoto H; Ishii A; Hirose S; Yamamoto H
    Brain Dev; 2020 Jan; 42(1):73-76. PubMed ID: 31492455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients.
    Archer HL; Evans J; Edwards S; Colley J; Newbury-Ecob R; O'Callaghan F; Huyton M; O'Regan M; Tolmie J; Sampson J; Clarke A; Osborne J
    J Med Genet; 2006 Sep; 43(9):729-34. PubMed ID: 16611748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKL5 alterations lead to early epileptic encephalopathy in both genders.
    Liang JS; Shimojima K; Takayama R; Natsume J; Shichiji M; Hirasawa K; Imai K; Okanishi T; Mizuno S; Okumura A; Sugawara M; Ito T; Ikeda H; Takahashi Y; Oguni H; Imai K; Osawa M; Yamamoto T
    Epilepsia; 2011 Oct; 52(10):1835-42. PubMed ID: 21770923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDKL5 gene-related epileptic encephalopathy: electroclinical findings in the first year of life.
    Melani F; Mei D; Pisano T; Savasta S; Franzoni E; Ferrari AR; Marini C; Guerrini R
    Dev Med Child Neurol; 2011 Apr; 53(4):354-60. PubMed ID: 21309761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aged heterozygous Cdkl5 mutant mice exhibit spontaneous epileptic spasms.
    Mulcahey PJ; Tang S; Takano H; White A; Davila Portillo DR; Kane OM; Marsh ED; Zhou Z; Coulter DA
    Exp Neurol; 2020 Oct; 332():113388. PubMed ID: 32585155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted gene panel sequencing in early infantile onset developmental and epileptic encephalopathy.
    Na JH; Shin S; Yang D; Kim B; Kim HD; Kim S; Lee JS; Choi JR; Lee ST; Kang HC
    Brain Dev; 2020 Jun; 42(6):438-448. PubMed ID: 32139178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic manifestations between male and female children with CDKL5 mutations.
    Liang JS; Huang H; Wang JS; Lu JF
    Brain Dev; 2019 Oct; 41(9):783-789. PubMed ID: 31122804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The three stages of epilepsy in patients with CDKL5 mutations.
    Bahi-Buisson N; Kaminska A; Boddaert N; Rio M; Afenjar A; Gérard M; Giuliano F; Motte J; Héron D; Morel MA; Plouin P; Richelme C; des Portes V; Dulac O; Philippe C; Chiron C; Nabbout R; Bienvenu T
    Epilepsia; 2008 Jun; 49(6):1027-37. PubMed ID: 18266744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Novel Variants Affecting CDKL5 Transcript Associated with Epileptic Encephalopathy.
    Neupauerová J; Štěrbová K; Vlčková M; Sebroňová V; Maříková T; Krůtová M; David S; Kršek P; Žaliová M; Seeman P; Laššuthová P
    Genet Test Mol Biomarkers; 2017 Oct; 21(10):613-618. PubMed ID: 28872899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late infantile epileptic encephalopathy: A distinct developmental and epileptic encephalopathy syndrome.
    Kacker S; Phitsanuwong C; Oetomo A; Nordli DR
    Epileptic Disord; 2024 Feb; 26(1):98-108. PubMed ID: 38100275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phenotypic spectrum of X-linked, infantile onset ALG13-related developmental and epileptic encephalopathy.
    Datta AN; Bahi-Buisson N; Bienvenu T; Buerki SE; Gardiner F; Cross JH; Heron B; Kaminska A; Korff CM; Lepine A; Lesca G; McTague A; Mefford HC; Mignot C; Milh M; Piton A; Pressler RM; Ruf S; Sadleir LG; de Saint Martin A; Van Gassen K; Verbeek NE; Ville D; Villeneuve N; Zacher P; Scheffer IE; Lemke JR
    Epilepsia; 2021 Feb; 62(2):325-334. PubMed ID: 33410528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXO28 causes developmental and epileptic encephalopathy with profound intellectual disability.
    Schneider AL; Myers CT; Muir AM; Calvert S; Basinger A; Perry MS; Rodan L; Helbig KL; Chambers C; Gorman KM; King MD; Donkervoort S; Soldatos A; Bönnemann CG; Spataro N; Gabau E; Arellano M; Cappuccio G; Brunetti-Pierri N; Rossignol E; Hamdan FF; Michaud JL; Balak C; Mefford HC; Scheffer IE
    Epilepsia; 2021 Jan; 62(1):e13-e21. PubMed ID: 33280099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.